Advertisement
Case Report| Volume 32, ISSUE 5, P2263-2270, October 2018

Hypoxemia After Percutaneous Mitral Valve Replacement: Management

Published:March 08, 2018DOI:https://doi.org/10.1053/j.jvca.2018.01.022
      PERCUTANEOUS MITRAL VALVULOPLASTY is a well-established procedure for the treatment of mitral stenosis.
      • Vahanian A.
      • Alfieri O.
      • Andreotti F.
      • et al.
      Guidelines on the management of the valvular heart disease (version 2012).
      More recently, percutaneous mitral valve repair and replacement (PMVR) procedures have been performed for both mitral stenosis and regurgitation, and offer a less invasive approach for high risk patients.
      • Vahanian A.
      • Alfieri O.
      • Andreotti F.
      • et al.
      Guidelines on the management of the valvular heart disease (version 2012).
      • Zamorano J.L.
      • Badano L.P.
      • Bruce C.
      • et al.
      EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease.
      • Yeh L.
      • Mashari A.
      • Montealegre-Gallegos M.
      • et al.
      Immediate closure of iatrogenic ASD after Mitra-Clip procedure prompted by acute right ventricular dysfunction.
      • Huntgeburth M.
      • Muller-Ehmsen J.
      • Baldus S.
      • et al.
      Postinterventional iatrogenic atrial septal defect with hemodynamically relevant left-to-right and right-to-left shunt as a complication of successful percutaneous mitral valve repair with the MitraClip.
      • Losi M.-A.
      • Strisciuglio T.
      • Stabile E.
      • et al.
      Iatrogenic atrial septal defect (iASD) after MitraClip system delivery: The key role of the PaO2/FiO2 ratio guiding post-procedural iASD closure.
      • Smith T.
      • McGinty P.
      • Bommer W.
      • et al.
      Prevalence and echocardiographic features of iatrogenic atrial septal defect after catheter-based mitral valve repair with the MitraClip system.
      • Ussia G.P.
      • Cammalleri V.
      • Marchei M.
      • et al.
      Hemodynamic patterns of residual intertribal communication after transcatheter MitraClip repair.
      The typical approach to PMVR is transapical through the left ventricular apex as it provides a more direct delivery of the valve.
      • Hamid N.B.
      • Khalique O.K.
      • Monaghan M.J.
      • et al.
      Transcatheter valve implantation in failed surgically inserted bioprosthesis.
      • Wilbring M.
      • Alexiou K.
      • Tugtekin S.M.
      • et al.
      Transapical transcatheter valve-in-valve implantation for deteriorated mitral valve bioprostheses.
      However, the mitral valve also can be repaired or replaced via a trans-septal approach.
      • Yeh L.
      • Mashari A.
      • Montealegre-Gallegos M.
      • et al.
      Immediate closure of iatrogenic ASD after Mitra-Clip procedure prompted by acute right ventricular dysfunction.
      • Huntgeburth M.
      • Muller-Ehmsen J.
      • Baldus S.
      • et al.
      Postinterventional iatrogenic atrial septal defect with hemodynamically relevant left-to-right and right-to-left shunt as a complication of successful percutaneous mitral valve repair with the MitraClip.
      • Losi M.-A.
      • Strisciuglio T.
      • Stabile E.
      • et al.
      Iatrogenic atrial septal defect (iASD) after MitraClip system delivery: The key role of the PaO2/FiO2 ratio guiding post-procedural iASD closure.
      • Smith T.
      • McGinty P.
      • Bommer W.
      • et al.
      Prevalence and echocardiographic features of iatrogenic atrial septal defect after catheter-based mitral valve repair with the MitraClip system.
      • Ussia G.P.
      • Cammalleri V.
      • Marchei M.
      • et al.
      Hemodynamic patterns of residual intertribal communication after transcatheter MitraClip repair.
      • Coylewright M.
      • Cabalka A.K.
      • Malouf A.J.A.
      • et al.
      Percutaneous mitral valve replacement using a transvenous, trans-septal approach. Transvenous mitral valve replacement.
      • Kliger C.
      • Angulo R.
      • Maranan L.
      • et al.
      Percutaneous complete repair of failed mitral valve prothesis simultaneous closure of mitral paravalvular leaks and transcatheter mitral valve implantation- single-center experience.
      One complication of trans-septal procedures is a residual iatrogenic atrial septal defect (iASD).
      • Yeh L.
      • Mashari A.
      • Montealegre-Gallegos M.
      • et al.
      Immediate closure of iatrogenic ASD after Mitra-Clip procedure prompted by acute right ventricular dysfunction.
      • Huntgeburth M.
      • Muller-Ehmsen J.
      • Baldus S.
      • et al.
      Postinterventional iatrogenic atrial septal defect with hemodynamically relevant left-to-right and right-to-left shunt as a complication of successful percutaneous mitral valve repair with the MitraClip.
      • Losi M.-A.
      • Strisciuglio T.
      • Stabile E.
      • et al.
      Iatrogenic atrial septal defect (iASD) after MitraClip system delivery: The key role of the PaO2/FiO2 ratio guiding post-procedural iASD closure.
      • Smith T.
      • McGinty P.
      • Bommer W.
      • et al.
      Prevalence and echocardiographic features of iatrogenic atrial septal defect after catheter-based mitral valve repair with the MitraClip system.
      • Ussia G.P.
      • Cammalleri V.
      • Marchei M.
      • et al.
      Hemodynamic patterns of residual intertribal communication after transcatheter MitraClip repair.
      • Hamid N.B.
      • Khalique O.K.
      • Monaghan M.J.
      • et al.
      Transcatheter valve implantation in failed surgically inserted bioprosthesis.
      • Wilbring M.
      • Alexiou K.
      • Tugtekin S.M.
      • et al.
      Transapical transcatheter valve-in-valve implantation for deteriorated mitral valve bioprostheses.
      • Coylewright M.
      • Cabalka A.K.
      • Malouf A.J.A.
      • et al.
      Percutaneous mitral valve replacement using a transvenous, trans-septal approach. Transvenous mitral valve replacement.
      • Kliger C.
      • Angulo R.
      • Maranan L.
      • et al.
      Percutaneous complete repair of failed mitral valve prothesis simultaneous closure of mitral paravalvular leaks and transcatheter mitral valve implantation- single-center experience.
      • Blaise G.
      • Langleben D.
      • Hubert B.
      Pulmonary arterial hypertension.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Cardiothoracic and Vascular Anesthesia
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Vahanian A.
        • Alfieri O.
        • Andreotti F.
        • et al.
        Guidelines on the management of the valvular heart disease (version 2012).
        Eur Heart J. 2012; 33: 2451-2496
        • Zamorano J.L.
        • Badano L.P.
        • Bruce C.
        • et al.
        EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease.
        J Am Soc Echocardiogr. 2011; 24: 937-965
        • Yeh L.
        • Mashari A.
        • Montealegre-Gallegos M.
        • et al.
        Immediate closure of iatrogenic ASD after Mitra-Clip procedure prompted by acute right ventricular dysfunction.
        J Cardiothorac Vasc Anesth. 2017; 31: 1304-1307
        • Huntgeburth M.
        • Muller-Ehmsen J.
        • Baldus S.
        • et al.
        Postinterventional iatrogenic atrial septal defect with hemodynamically relevant left-to-right and right-to-left shunt as a complication of successful percutaneous mitral valve repair with the MitraClip.
        Int J Cardiol. 2013; 168: e3-e5
        • Losi M.-A.
        • Strisciuglio T.
        • Stabile E.
        • et al.
        Iatrogenic atrial septal defect (iASD) after MitraClip system delivery: The key role of the PaO2/FiO2 ratio guiding post-procedural iASD closure.
        Int J Cardiol. 2015; 197: 85-86
        • Smith T.
        • McGinty P.
        • Bommer W.
        • et al.
        Prevalence and echocardiographic features of iatrogenic atrial septal defect after catheter-based mitral valve repair with the MitraClip system.
        Catheter Cardiovasc Interv Off J Soc Card Angiogr Interv. 2012; 80: 678-685
        • Ussia G.P.
        • Cammalleri V.
        • Marchei M.
        • et al.
        Hemodynamic patterns of residual intertribal communication after transcatheter MitraClip repair.
        J Cardiovasc Med. 2014; 15: 343-349
        • Hamid N.B.
        • Khalique O.K.
        • Monaghan M.J.
        • et al.
        Transcatheter valve implantation in failed surgically inserted bioprosthesis.
        JACC Cardiovasc Imaging. 2015; 8: 960-979
        • Wilbring M.
        • Alexiou K.
        • Tugtekin S.M.
        • et al.
        Transapical transcatheter valve-in-valve implantation for deteriorated mitral valve bioprostheses.
        Ann Thorac Surg. 2013; 95: 111-118
        • Coylewright M.
        • Cabalka A.K.
        • Malouf A.J.A.
        • et al.
        Percutaneous mitral valve replacement using a transvenous, trans-septal approach. Transvenous mitral valve replacement.
        J Am Coll Cardiol Cardiovascular Interventions. 2015; 8: 850-857
        • Kliger C.
        • Angulo R.
        • Maranan L.
        • et al.
        Percutaneous complete repair of failed mitral valve prothesis simultaneous closure of mitral paravalvular leaks and transcatheter mitral valve implantation- single-center experience.
        EuroIntervention. 2015; 10: 1-2
        • Blaise G.
        • Langleben D.
        • Hubert B.
        Pulmonary arterial hypertension.
        Anesthesiology. 2003; 99: 1415-1432
        • Gan H.-L.
        The management of acute pulmonary arterial hypertension.
        Cardiovascular Therapeutics. 2011; 29: 153-175
        • Guarrzi M.
        • Borlaug B.A.
        Pulmonary hypertension due to left heart disease.
        Circulation. 2012; 126: 975-990
        • Strumpher J.
        • Jacobsohn E.
        Pulmonary hypertension and right ventricular dysfunction: Physiology and perioperative management.
        J Cardiothorac Vasc Anesth. 2011; 25: 687-704
        • Vachiery J.-L.
        • Adir Y.
        • Barbera J.A.
        • et al.
        Pulmonary hypertension due to left heart diseases.
        J Am Coll Cardiol. 2013; 62: D100-D108
        • Haraldsson S.A.
        • Kieler-Jensen N.
        • Ricksten S.E.
        The additive pulmonary vasodilatory effects of inhaled prostacyclin and inhaled milrinone in post cardiac surgery patients with pulmonary hypertension.
        Anesth Analg. 2001; 93: 1439-1445
        • Denault A.Y.
        • Bussieres J.S.
        • Arellano R.
        • et al.
        A multicentre randomized-controlled trial of inhaled Milrinone in high-risk cardiac surgical patients.
        Can J Anaesth. 2016; 63: 1140-1153
        • Elmi-Sarabi M.
        • Deschamps A.
        • Delisle S.
        • et al.
        Aerosolized vasodilators for the treatment of pulmonary hypertension in cardiac surgical patients: A systemic review and meta-analysis.
        Anesth Analg. 2017; 125: 393-402
        • Lamarche Y.
        • Malo O.
        • Thorin E.
        • et al.
        Inhaled but not intravenous milrinone prevents pulmonary endothelial dysfunction after cardiopulmonary bypass.
        J Thorac Cardiovasc Surg. 2005; 130: 83-92
        • Solina A.
        • Papp D.
        • Ginsberg S.
        • et al.
        A comparison of inhaled nitric oxide and Milrinone for the treatment of pulmonary hypertension in adults cardiac surgery patients.
        J Cardiothorac Vasc Anesth. 2000; 14: 12-17
        • Cheung A.
        • Webb J.G.
        • Barbanti M.
        • et al.
        5-year experience with transcatheter transapical mitral valve-in-valve implantation for bioprosthetic valve dysfunction.
        J Am Coll Cardiol. 2013; 61: 1759-1766
        • Descoutures F.
        • Himbert D.
        • Maisano F.
        • et al.
        Transcatheter valve-in-ring implantation after failure of surgical mitral repair.
        Eur J Cardiothorac Surg. 2013; 44: e8-e15
        • Cavalcante J.L.
        • Rodriguez L.L.
        • Kapadia S.
        • et al.
        Role of echocardiography in percutaneous mitral valve interventions.
        JACC Cardiovasc Imaging. 2012; 5: 733-746
        • Kronzon I.
        • Tunick P.A.
        • Goldfarb A.
        • et al.
        Echocardiographic and hemodynamic characteristics of atrial septal defects created by percutaneous valvuloplasty.
        J Am Soc Echocardiogr. 1990; 3: 64-71
        • Yoshida K.
        • Yoshikawa J.
        • Akasaka T.
        • et al.
        Assessment of left-to-right atrial shunting after percutaneous mitral valvuloplasty by transesophageal color Doppler flow-mapping.
        Circulation. 1989; 80: 1521-1526
        • Nigri A.
        • Alessandri N.
        • Martuscelli E.
        • et al.
        Clinical significance of small left-to-right shunts after percutaneous mitral valvuloplasty.
        Am Heart J. 1993; 125: 783-786
        • Sarkar M.
        • Niranjian N.
        • Banval P.K.
        Mechanisms of hypoxemia.
        Lung India. 2017; 34: 47-60
        • Henig N.R.
        • Pierson D.J.
        Mechanisms of hypoxemia.
        Respir Care Clin N Am. 2000; 6: 501-521
        • Vodoz J.-F.
        • Cottin V.
        • Glerant J.-C.
        • et al.
        Right-to-left shunt with hypoxemia in pulmonary hypertension.
        BMC Cardiovasc Disord. 2009; 10: 1-14
        • Melao F.
        • Cruz C.
        • Noya R.
        • et al.
        Hypoxia and cyanosis due to unusual right-to-left shunt in a patient with an atrial septal defect.
        J Cardiovasc Dis Diag. 2015; 3: 1-3
        • DiNardo J.A.
        • Shula A.C.
        • McGowan F.X.
        Anesthesia for congenital heart surgery.
        in: Davis P.J. Cladis F.P. Smith’s Anesthesia for Infants and Children, 9th edition. Elsevier, Philadelphia, PA2017: 633-698
        • Kulik T.J.
        Pulmonary hypertension caused by pulmonary venous hypertension.
        Pulm Circ. 2014; 4: 581-595
        • Lowson S.
        Inhaled alternatives to nitric oxide.
        Anesthesiology. 2002; 96: 1504-1513
        • Choo I.-J.
        • Hong G.-R.
        • Lee S.H.
        • et al.
        Differences in characteristics, left atrial reverse remodeling, and functional outcomes after mitral valve replacement in patients with low-gradient very severe mitral stenosis.
        J Am Soc Echocardiogr. 2016; 29: 759-767
        • Streitz J.M.
        • Maggs P.R.
        Fatal hypoxemia following mitral valve replacement.
        Ann Thorac Surg. 1988; 46: 104-105
        • Sun X.-G.
        • Hansen J.E.
        • Oudiz R.J.
        • et al.
        Gas exchange detection of exercise-induced right-to-left shunt in patients with primary pulmonary hypertension.
        Circulation. 2002; 105: 54-60
        • Kwak Y.L.
        • Lee C.S.
        • Park Y.H.
        • et al.
        The effect of phenylephrine and norepinephrine in patients with chronic pulmonary hypertension.
        Anesthesia. 2002; 57: 9-14
        • Hirsch L.J.
        • Rooney M.W.
        • Wat S.S.
        • et al.
        Norepinephrine and phenylephrine effects on right ventricular function in experimental canine pulmonary embolism.
        Chest. 1991; 100: 796-801
        • Mathru M.
        • Venus B.
        • Smith R.A.
        • et al.
        Treatment of low cardiac output complicating acute pulmonary hypertension in normovolemic goats.
        Critical Care Medicine. 1986; 14: 120-124
        • Ducas J.
        • Duval D.
        • Dasilva H.
        • et al.
        Treatment of canine pulmonary hypertension: Effects of norepinephrine and isoproterenol on pulmonary vascular pressure-flow characteristics.
        Circulation. 1987; 75: 235-242
        • Cheung P.-Y.
        • Barrington K.-J.
        The effects of dopamine and epinephrine on hemodynamics and oxygen metabolism in hypoxic anesthetized piglets.
        Critical Care. 2001; 5: 158-166
        • D’Ambra M.N.
        • LaRaia P.J.
        • Philbin D.M.
        • et al.
        Prostaglandin E1: A new therapy for refractory right heart failure and pulmonary hypertension after mitral valve replacement.
        J Thorac Cardiovasc Surg. 1985; 89: 567-572
        • Schmid E.R.
        • Burki C.
        • Engel M.H.C.
        • et al.
        Inhaled nitric oxide versus intravenous vasodilators in severe pulmonary hypertension after cardiac surgery.
        Anesth Analg. 1999; 89: 1108-1115
        • Packer M.
        • Halperin J.L.
        • Brooks K.M.
        • et al.
        Nitroglycerin therapy in the management of pulmonary hypertensive disorders.
        Am J Medicine. 1984; 76: 67-75
        • Pearl R.G.
        • Rosenthal M.H.
        • Schroeder J.S.
        • et al.
        Acute hemodynamic effects of nitroglyercin in pulmonary hypertension.
        Ann Intern Med. 1983; 99: 9-13
        • Pappert D.
        • Busch T.
        • Gerlach H.
        • et al.
        Aerosolized prostacyclin versus inhaled nitric oxide in children with severe acute respiratory distress syndrome.
        Anesthesiologist. 1995; 82: 1507-1511
        • Sablotzi A.
        • Starzmann W.
        • Scheubel R.
        • et al.
        Selective pulmonary vasodilation with inhaled aerosilized Milrinone in heart transplant candidates.
        Can J Anesthesia. 2005; 52: 1076-1082
        • Lamarche Y.
        • Perrault L.P.
        • Maltais S.
        • et al.
        Preliminary experience with inhaled milrinone in cardiac surgery.
        Eur J Cardiothorac Surg. 2007; 31: 1081-1087